Not applicableStudy completedNCT03966105What this trial is testingPrevalence of Wild Type ATTRWho this might be right forWild-type Transthyretin Amyloidosis Oncology Institute of Southern Switzerland 94
Not applicableWithdrawnNCT07080268What this trial is testingValidation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.Who this might be right forAmyloidosis in Transthyretin (TTR)Hereditary Amyloidosis, Transthyretin-Related Hospital General de Niños Pedro de Elizalde
Not applicableWithdrawnNCT02713880What this trial is testingBiomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)Who this might be right forTransthyretin AmyloidosisTransthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin Amyloid Cardiopathy CENTOGENE GmbH Rostock
Large-scale testing (Phase 3)Study completedNCT04622046What this trial is testingALXN2060 in Japanese Participants With Symptomatic ATTR-CMWho this might be right forSymptomatic Transthyretin Amyloid Cardiomyopathy Alexion Pharmaceuticals, Inc. 25
Post-approval studies (Phase 4)Looking for participantsNCT07298044What this trial is testingLearn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to AcoramidisWho this might be right forTransthyretin Amyloid Cardiomyopathy Bayer 50
Not applicableStudy completedNCT06393465What this trial is testingReal-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid CardiomyopathyWho this might be right forTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT00630864What this trial is testingThe Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin AmyloidosisWho this might be right forTransthyretin-associated Amyloidosis With Polyneuropathy Pfizer 21
Testing effectiveness (Phase 2)WithdrawnNCT02627820What this trial is testingThe Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the HeartWho this might be right forAmyloidosis Brigham and Women's Hospital
Not applicableStudy completedNCT07343999What this trial is testingEFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac AmyloidosisWho this might be right forTransthyretin Cardiac Amyloidosis Universidad de Burgos 47
Large-scale testing (Phase 3)Looking for participantsNCT06563895What this trial is testingAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantWho this might be right forAmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+3 more Eidos Therapeutics, a BridgeBio company 587
Not applicableEnded earlyNCT05259072What this trial is testingCarDIo-ttranSSfOrm nucLEar Imaging StudyWho this might be right forAmyloidosisTransthyretin Amyloid Cardiomyopathy Oregon Health and Science University 4
Not applicableUnknownNCT06328075What this trial is testingArtificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac AmyloidosisWho this might be right forAmyloid CardiomyopathyTransthyretin Amyloid CardiomyopathyTransthyretin Cardiac Amyloidosis Algalarrondo Vincent 15,000
Not applicableLooking for participantsNCT05577819What this trial is testingPrevalence and Prediction of ATTR in Ambulatory Patients With HFpEFWho this might be right forTransthyretin AmyloidosisHeart FailureHeart Failure, Diastolic+1 more Massachusetts General Hospital 515